Drug Repositioning for Alzheimer’s Disease Based on Systematic ‘omics’ Data Mining


Traditional drug development for Alzheimer's disease (AD) is costly, time consuming and burdened by a very low success rate. An alternative strategy is drug repositioning, redirecting existing drugs for another disease. The large amount of biological data accumulated to date warrants a comprehensive investigation to better understand AD pathogenesis and… (More)
DOI: 10.1371/journal.pone.0168812